Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Diabetes Science and Technology|November 4, 2009
Indication-based ordering: a new paradigm for glycemic control in hospitalized inpatientsJoshua Lee, Brian Clay, Ziband Zelazny, et al.
Journal of Hospital Medicine|February 19, 2018
Impact of a Multicenter, Mentored Quality Collaborative on Hospital-Associated Venous ThromboembolismIan Jenkins, Tamra O'Bryan, Janet Holdych, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|October 30, 2014
The physician mentored implementation model: a promising quality improvement framework for health care changeJing Li, Keiki Hinami, Luke O Hansen, et al.
Journal of Hospital Medicine|February 6, 2014
Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centersRaman Khanna, Gregory Maynard, Banafsheh Sadeghi, et al.
Journal of Hospital Medicine|October 9, 2012
Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: a case-control studyBanafsheh Sadeghi, Patrick S Romano, Gregory Maynard, et al.
Medical Care|April 5, 2013
Improved coding of postoperative deep vein thrombosis and pulmonary embolism in administrative data (AHRQ Patient Safety Indicator 12) after introduction of new ICD-9-CM diagnosis codesBanafsheh Sadeghi, Richard H White, Gregory Maynard, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|January 29, 2009
Intern to attending: assessing stress among physiciansErin R Stucky, Timothy R Dresselhaus, Adrian Dollarhide, et al.
Medical Care|April 5, 2013
Predictive value of the present-on-admission indicator for hospital-acquired venous thromboembolismRaman R Khanna, Sharon B Kim, Ian Jenkins, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis|September 1, 2022
Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER TrialAlex C Spyropoulos, Mark Goldin, Walter Ageno, et al.
Journal of the American Heart Association|October 7, 2022
Benefit-Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical IllnessGary E Raskob, Walter Ageno, Gregory Albers, et al.
Pageof 2